Epitranscriptomic profiling of VSMC phenotypes reveals uridine modifications linked to post-transcriptional regulation

This study utilizes direct RNA sequencing to reveal that distinct epitranscriptomic landscapes, particularly enhanced uridine modifications within GUUUU motifs in pro-inflammatory vascular smooth muscle cells, constitute a novel regulatory layer governing post-transcriptional mechanisms critical to atherosclerosis progression.

The Gist

The Big Picture: The "Post-It Note" on the Recipe Book

Imagine your body's cells are like a busy kitchen. The DNA is the master recipe book stored safely in the pantry. The mRNA (messenger RNA) is a photocopy of a specific recipe that the chefs (ribosomes) take to the stove to cook a meal (protein).

For a long time, scientists thought the only way to control what gets cooked was to decide which recipes to photocopy (turning genes on or off). But this new study discovered a hidden layer of control: Epitranscriptomics.

Think of epitranscriptomics as Post-it notes, highlighters, or coffee stains that people stick onto the photocopies after they are made. These marks don't change the recipe itself, but they tell the chef: "Cook this faster," "Throw this away," or "Don't let the sous-chef (a microRNA) stop you from cooking."

The Cast of Characters: The Smooth Muscle Cells

The study focuses on Vascular Smooth Muscle Cells (VSMCs). These are the cells that line your blood vessels. They are incredibly flexible (plastic) and can change their "personality" depending on the environment:

1. The "Guardian" (Atheroprotective): When treated with a calming signal (TGF-β1), these cells become quiet, strong, and build a protective wall around fatty deposits in the artery. They are like the peaceful gardeners keeping the road smooth.
2. The "Chaos Agent" (Pro-atherogenic): When attacked by inflammation signals (PDGF-BB and IL-1β), these cells panic. They become energetic, aggressive, and start building messy, unstable structures. They are like the frantic construction crew causing traffic jams and roadblocks. This state leads to heart disease (atherosclerosis).

The Discovery: The "Uridine" Highlighter

The researchers wanted to know: What happens to the "Post-it notes" on the recipe copies when the cell switches from a Guardian to a Chaos Agent?

They used a high-tech microscope called Oxford Nanopore sequencing to read the RNA molecules directly, looking for chemical marks.

Here is what they found:

• The "U" Mark: They discovered that in the "Chaos Agent" cells, there was a massive increase in a specific type of Post-it note attached to the letter "U" (Uridine) in the RNA.
• The Secret Code: These "U" marks weren't random. They loved a specific pattern: GUUUU. It's like finding that every time the kitchen gets chaotic, someone highlights the phrase "Order Up!" in a specific font.
• Where they hide: These marks were mostly found at the very end of the recipe (the 3' end), often right where the "Stop Cooking" signal is, or where other regulators (microRNAs) try to grab the paper.

How Does This Change the Cell?

The study suggests these "U" marks act like a volume knob or a security guard for the cell's instructions.

1. The Volume Knob (Poly-A Tails): The researchers found that cells with more "U" marks had longer "tails" on their recipes. Usually, a longer tail means the recipe is more stable and gets cooked more. However, the relationship was complex, suggesting these marks fine-tune exactly how much protein is made.
2. The Security Guard (miRNA): Imagine a security guard (a microRNA) whose job is to stop the chef from cooking a dangerous dish. The "U" marks seem to act like a shield. By placing a mark right where the security guard tries to grab the paper, the cell blocks the guard. The recipe stays safe, and the protein gets made.
   • Example: They looked at a gene called ITGB1. In the chaotic cells, a "U" mark appeared that seemed to block the security guard, allowing the cell to produce more of a protein that helps it move and change shape aggressively.

Why Does This Matter?

This is a game-changer for understanding heart disease.

• New Clues: We used to think heart disease was just about which genes were turned on or off. Now we know it's also about how the instructions are marked.
• New Targets: If we can figure out exactly which "pen" is writing these "U" marks, we might be able to stop the "Chaos Agent" cells from becoming aggressive. We could potentially develop drugs that erase these Post-it notes, forcing the cells to calm down and become "Guardians" again.
• Biomarkers: Since these marks are unique to the disease state, we might one day be able to detect them in a simple blood test to see how severe a patient's heart disease is before a heart attack happens.

The Bottom Line

This paper reveals that Vascular Smooth Muscle Cells have a secret language written in chemical marks on their RNA. When these cells switch from being protective to being dangerous (leading to heart attacks), they start slapping a specific "U" sticker on their instructions. This sticker changes how the cell reads the recipe, making it more aggressive and unstable. Understanding this hidden layer of regulation opens up exciting new ways to treat and prevent cardiovascular disease.

Technical Summary

1. Problem Statement

Vascular Smooth Muscle Cells (VSMCs) exhibit significant phenotypic plasticity, transitioning between a contractile, atheroprotective state and a synthetic, pro-inflammatory, pro-atherogenic state. This transition is a critical driver of atherosclerosis progression. While transcriptional, epigenetic, and non-coding RNA mechanisms regulating this switch are well-characterized, the role of epitranscriptomics (chemical modifications of RNA bases) in VSMC phenotypic transitions remains largely unexplored. Previous studies have focused on specific modifications (e.g., m6A) or specific disease contexts, lacking a hypothesis-free, transcriptome-wide view of how RNA modifications differ between protective and pathological VSMC states.

2. Methodology

The study employed a multi-omics approach combining cell culture models, short-read and long-read sequencing, proteomics, and computational biology.

• Cell Culture Model: Primary human VSMCs were cultured on collagen I hydrogels to maintain a contractile phenotype. Four distinct conditions were established:
  • C3 (Atheroprotective): Treated with TGF-β1 (induces contractile, matrix-producing state).
  • C4 (Pro-atherogenic): Treated with PDGF-BB + IL-1β (induces high-energy, pro-inflammatory state).
  • C2 (Oxidative Stress-Prone): Intermediate state (TGF-β1 followed by PDGF-BB/IL-1β).
  • C1 (Oxidatively Stressed): C2 state with additional PDGF-BB boost.
  • C5: Untreated control.
• Sequencing:
  • Short-read (Illumina): mRNA-Seq and small RNA-Seq for gene expression and miRNA profiling.
  • Long-read (Oxford Nanopore Technologies - ONT): Direct RNA sequencing (SQK-RNA002) to detect RNA base modifications without cDNA conversion bias.
• Proteomics: Label-free quantitative mass spectrometry (LC-MS/MS) to measure protein abundance.
• Bioinformatics & Analysis:
  • Modification Detection: Used xPore to analyze ONT direct RNA-Seq data, identifying differentially modified RNA bases (DMRs) by detecting significant differences in electric current signals between modified and unmodified bases.
  • Structural Prediction: Used ViennaRNA and Forgi to predict RNA secondary structures and assess if DMRs occur in specific structural elements (e.g., loops, stems).
  • miRNA Analysis: Predicted miRNA binding sites (seed matches) within DMR regions using TargetScan and miRTarBase.
  • Integration: Correlated RNA modification rates with transcript abundance (Illumina/ONT) and protein levels (MS).

3. Key Contributions

• First Hypothesis-Free Epitranscriptome of VSMCs: This study provides the first comprehensive, untargeted map of RNA modifications across distinct VSMC phenotypes using ONT direct RNA sequencing.
• Discovery of a Novel Uridine Motif: Identified a specific, highly enriched sequence motif (GUUUU) associated with uridine modifications in pro-inflammatory VSMCs, which had not been previously described in this context.
• Mechanistic Link to Post-Transcriptional Regulation: Demonstrated that RNA modifications (specifically uridines) are not random but are functionally linked to:
  • Poly(A) tail length dynamics.
  • RNA secondary structure accessibility (specifically interior loops in 3'-UTRs).
  • Modulation of miRNA binding efficiency.
• Multi-Omics Validation: Integrated transcriptomics, epitranscriptomics, and proteomics to show that DMRs correlate with changes in protein abundance, suggesting a direct role in translational regulation.

4. Key Results

• Phenotypic Characterization:

  • C3 (TGF-β1): Contractile, low metabolic activity, high ECM production (atheroprotective).
  • C4 (PDGF-BB/IL-1β): Synthetic, high metabolic/glycolytic activity, pro-inflammatory cytokine production (pro-atherogenic).
  • PCA analysis confirmed distinct separation between C3/C5 and C1/C2/C4.

• RNA Modification Landscape:

  • Up to 4-5% of mRNA bases were found to be modified.
  • The comparison between C3 and C4 yielded the highest number of differentially modified sites (2.1 million positions analyzed; ~2,186 high-confidence DMRs after filtering).
  • Uridine (U) was the most frequently modified base in the pro-atherogenic state (C4).
  • Motif Analysis: The GY-U-YY motif (where Y = C or U) was dominant. Specifically, the GUUUU 5-mer showed an ~80-fold enrichment in modified sites.
  • Location: DMRs were enriched near stop codons and in the 3'-UTR, particularly in accessible interior loops of RNA secondary structures.
  • Oxidative Stress: Contrary to expectations, endogenous oxidative stress did not significantly increase 8-oxo-guanosine (8-oxoGuo) detection, suggesting the observed changes are cytokine-driven rather than purely oxidation-driven.

• Functional Consequences:

  • Poly(A) Tail Dynamics: Transcripts with higher numbers of DMRs exhibited longer Poly(A) tails in the pro-atherogenic state. There was a negative correlation between Poly(A) tail length and protein abundance for specific genes (e.g., NAMPT, FN1), suggesting DMRs influence mRNA stability and translation efficiency.
  • miRNA Binding: DMRs were found within miRNA seed binding sites. For example, in the ITGB1 transcript, a modified adenosine in a miR-493-5p binding site showed reduced modification in C4, potentially reducing miRNA-mediated repression and increasing protein levels.
  • Protein Correlation: Genes with >3 DMRs showed a strong correlation between transcript fold-change and protein fold-change, indicating DMRs help shape the final proteome.

• Enzyme Expression:

  • While few individual modification enzymes were significantly differentially expressed, global signatures of mRNA-modifying genes (e.g., PUS7, TET1) separated the phenotypes, suggesting an orchestrated regulatory program.

5. Significance and Implications

• Novel Regulatory Layer: The study establishes epitranscriptomics as a critical, previously underappreciated layer of regulation in VSMC phenotypic switching, distinct from transcriptional and epigenetic control.
• Atherosclerosis Mechanism: The findings suggest that pro-inflammatory cytokines (PDGF-BB/IL-1β) alter the epitranscriptomic landscape (specifically uridine modifications) to stabilize pro-atherogenic transcripts and destabilize atheroprotective ones, driving disease progression.
• Therapeutic Potential:
  • Biomarkers: Specific RNA modification patterns could serve as biomarkers for disease severity or plaque instability.
  • Therapeutics: Since DMRs can modulate miRNA binding, targeting these modification sites or the enzymes responsible could offer new strategies to stabilize VSMCs in an atheroprotective state.
• Technical Advancement: The study validates the utility of ONT direct RNA sequencing combined with xPore for hypothesis-free discovery of RNA modifications in complex biological systems, overcoming the limitations of antibody-based or enzyme-specific methods.

Limitations Noted: The study acknowledges that ONT chemistry (RNA002) limits the specific classification of modification types (e.g., distinguishing pseudouridine from other uridine mods), and the mapping of isoform-specific DMRs to protein levels is constrained by peptide-based proteomics resolution. Future work requires targeted validation of specific modification types.